Sequent Scientific Ltd

Sequent Scien. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sequent Scientific Ltd

₹ 202 4.94%
22 Nov - close price
sequent.in BSE: 512529 NSE: SEQUENT
About

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

Key Points

Business segments
The company has 2 business segments: Formulation and API. [1]

Website BSE NSE - BE
  • Market Cap ₹ 5,045 Cr.
  • Current Price ₹ 202
  • High / Low ₹ 241 / 91.8
  • Stock P/E 253
  • Book Value ₹ 44.4
  • Dividend Yield 0.00 %
  • ROCE 0.53 %
  • ROE 0.22 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 4.55 times its book value
  • The company has delivered a poor sales growth of 0.27% over past five years.
  • Company has a low return on equity of 0.35% over last 3 years.
  • Earnings include an other income of Rs.48.9 Cr.
  • Debtor days have increased from 68.8 to 97.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of Nifty Microcap 250 BSE Healthcare BSE Allcap Nifty Total Market BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
50.11 59.19 63.67 64.86 54.23 57.00 46.60 40.42 49.12 42.21 36.77 57.67 41.99
54.69 56.41 58.45 66.85 63.81 65.74 52.64 49.49 56.82 46.36 42.53 59.65 44.09
Operating Profit -4.58 2.78 5.22 -1.99 -9.58 -8.74 -6.04 -9.07 -7.70 -4.15 -5.76 -1.98 -2.10
OPM % -9.14% 4.70% 8.20% -3.07% -17.67% -15.33% -12.96% -22.44% -15.68% -9.83% -15.66% -3.43% -5.00%
10.41 5.70 5.77 5.88 6.73 7.62 8.01 3.45 9.87 13.44 12.98 10.84 11.63
Interest 0.28 0.56 0.61 0.35 0.58 0.72 0.87 0.98 1.21 1.15 1.01 0.81 1.00
Depreciation 2.54 2.40 2.34 2.38 2.25 2.15 2.33 2.43 2.35 2.05 2.11 2.00 2.12
Profit before tax 3.01 5.52 8.04 1.16 -5.68 -3.99 -1.23 -9.03 -1.39 6.09 4.10 6.05 6.41
Tax % -42.52% 18.84% 17.16% 27.59% -28.70% -69.42% 34.15% -24.70% -34.53% 24.79% 8.29% 25.62% 33.54%
4.29 4.47 6.65 0.84 -4.05 -1.23 -1.65 -6.80 -0.92 4.58 3.76 4.50 4.26
EPS in Rs 0.17 0.18 0.27 0.03 -0.16 -0.05 -0.07 -0.27 -0.04 0.18 0.15 0.18 0.17
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
236 341 384 395 91 106 166 227 265 220 223 169 179
254 347 330 358 121 124 164 205 230 220 249 195 193
Operating Profit -19 -6 54 36 -31 -18 3 22 35 -1 -26 -27 -14
OPM % -8% -2% 14% 9% -34% -17% 2% 10% 13% -0% -12% -16% -8%
3 -55 57 15 34 432 14 15 17 28 28 40 49
Interest 25 31 43 16 0 0 3 5 3 2 3 4 4
Depreciation 23 23 25 24 3 4 7 9 9 10 9 9 8
Profit before tax -63 -114 43 10 -0 409 6 23 41 16 -10 -0 23
Tax % -13% 0% 4% 1% 0% 1% -22% 6% 21% 6% -38% -358%
-54 -114 41 10 -0 406 8 21 32 15 -6 1 17
EPS in Rs -4.54 -8.38 2.71 0.44 -0.00 16.68 0.31 0.86 1.29 0.60 -0.24 0.02 0.68
Dividend Payout % 0% 0% 0% 0% 0% 1% 65% 0% 39% 0% 0% 0%
Compounded Sales Growth
10 Years: -7%
5 Years: 0%
3 Years: -14%
TTM: -8%
Compounded Profit Growth
10 Years: 7%
5 Years: -21%
3 Years: -59%
TTM: 559%
Stock Price CAGR
10 Years: 9%
5 Years: 24%
3 Years: 8%
1 Year: 64%
Return on Equity
10 Years: 6%
5 Years: 1%
3 Years: 0%
Last Year: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 23 27 30 48 49 49 49 50 50 50 50 50 50
Reserves 74 13 98 1,145 1,209 900 868 837 980 991 1,008 1,037 1,059
265 350 341 49 87 0 44 35 6 17 20 47 37
177 171 181 107 106 29 57 76 67 66 44 54 38
Total Liabilities 540 560 650 1,348 1,450 977 1,019 997 1,102 1,124 1,123 1,188 1,183
205 220 201 170 188 24 52 69 66 67 57 43 45
CWIP 22 11 9 20 32 3 0 4 4 1 2 5 5
Investments 55 65 183 897 891 687 788 758 685 659 633 640 642
259 264 257 262 340 264 178 167 347 397 431 500 492
Total Assets 540 560 650 1,348 1,450 977 1,019 997 1,102 1,124 1,123 1,188 1,183

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-13 -42 -25 100 -24 -4 74 30 2 9 38 -27
-31 -61 24 -359 -47 16 -114 -18 17 -4 -51 5
39 108 8 247 71 -12 40 -11 -21 7 0 22
Net Cash Flow -5 4 7 -12 0 -0 0 2 -2 12 -13 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 109 85 94 68 455 270 94 65 84 87 22 97
Inventory Days 228 196 126 94 315 64 98 101 154 228 129 117
Days Payable 402 262 132 123 352 113 203 208 197 193 99 130
Cash Conversion Cycle -66 19 88 39 417 221 -11 -41 41 122 53 84
Working Capital Days 16 51 55 129 795 333 55 17 73 114 54 96
ROCE % -11% -6% 26% 3% 0% 35% 1% 3% 5% 2% -1% 1%

Shareholding Pattern

Numbers in percentages

19 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
53.02% 53.02% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.78% 52.76%
6.42% 5.84% 6.45% 6.57% 6.25% 5.89% 6.27% 6.03% 6.12% 6.16% 5.69% 6.45%
2.13% 2.04% 2.27% 2.79% 2.81% 2.92% 2.92% 3.23% 7.23% 7.59% 8.06% 9.99%
37.89% 38.60% 38.10% 37.48% 37.76% 38.00% 37.64% 37.57% 33.69% 33.29% 33.30% 30.63%
0.54% 0.51% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.17% 0.17% 0.17% 0.17%
No. of Shareholders 1,67,8121,91,0921,97,1761,93,9541,96,2311,91,8751,87,4741,84,5211,72,8531,66,5931,63,6931,54,603

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls